SPX4,297.14+16.99 0.40%
DIA339.37+1.54 0.46%
IXIC13,128.05+80.87 0.62%

--Goldman Sachs Raises Myovant Sciences Price Target to $10 From $9, Maintains Neutral Rating

--Goldman Sachs Raises Myovant Sciences Price Target to $10 From $9, Maintains Neutral Rating

MT Newswires · 07/28/2022 07:11

Please log in to view news